NEW YORK (
) hit a new 52-week low Friday as it is currently trading at $15.97, below its previous 52-week low of $16.05 with 91,166 shares traded as of 9:57 a.m. ET. Average volume has been 2.3 million shares over the past 30 days.
Warner Chilcott has a market cap of $4.3 billion and is part of the
industry. Shares are down 2.1% year to date as of the close of trading on Thursday.
Warner Chilcott plc, a specialty pharmaceutical company, focuses on the development, manufacture, and promotion of branded pharmaceutical products in women's healthcare, gastroenterology, dermatology, and urology segments in North America and western Europe markets. The company has a P/E ratio of 13.3, below the average drugs industry P/E ratio of 36 and below the S&P 500 P/E ratio of 17.7.
- Practice your WCRX trading strategies and win cash in our stock game.
TheStreet Ratings rates Warner Chilcott as a
. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and generally poor debt management. You can view the full
or get investment ideas from our